MyFinsight
Home
About
Contact
Back
Income Statement
ADIAL PHARMACEUTICALS, INC. (ADIL)
source: myfinsight.com
Download
Download image
Net loss
-$1,958,556
(20.33%↑ Y/Y)
Total other income
(expense)
-$75,844
Loss from operations
-$1,882,712
(17.69%↑ Y/Y)
Interest income
$23,747
Loss on equity method
investment
-$98,730
Total operating
expenses
$1,882,712
Other income
(expenses)
-$861
General and
administrative expenses
$1,150,397
Research and development
expenses
$732,315
Back